Medical/Pharmaceuticals

Henlius Novel Anti PD-L1/TIGIT Bispecific Antibody Received Clinical Trial Approval in Australia

SHANGHAI, Nov. 25, 2021 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that the filing of a clinical trial for HLX301, a Recombinant Humanized Anti-PDL1 and Anti-TIGIT Bispecific Antibody, in Patients with locally advanced or metastatic solid tumours has been approved by the ...

2021-11-25 17:27 4829

More cancer patients in Africa to benefit from advanced radiation therapy with Elekta Unity MR-Linac

STOCKHOLM, Nov. 25, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that its latest African order for Elekta Unity MR-Linac comes less than six months after the company introduced its ACCESS 2025 strategy, which includes giving more than 300 million people access to radiation therapy with...

2021-11-25 17:06 2761

Elekta: Interim report, May-October 2021/22

STOCKHOLM, Nov. 25, 2021 /PRNewswire/ -- The increasing need for investments in cancer care and radiotherapy across the globe supported a gradual market recovery during the quarter. Our orders grew with double digits, and despite the continued global supply chain challenges we secured good revenu...

2021-11-25 16:48 3255

Innovative €250,000 Parenteral Nutrition Research Grant Awarded by Fresenius Kabi

BAD HOMBURG, Germany, Nov. 25, 2021 /PRNewswire/ -- Fresenius Kabi was delighted to announce the winner of their innovative JUMPstart education program and research grant onSeptember 10, 2021. JUMPstart is an initiative that aims to nurture research in the field of parenteral nutrition through th...

2021-11-25 15:45 4768

Sartorius significantly expands activities in South Korea

SHANGHAI, Nov. 25, 2021 /PRNewswire/ -- The life science company Sartorius is investing around270 million euros, some 300 million U.S. dollars, through the end of 2024 in expanding its activities inSouth Korea. In the country's biopharma hub Songdo in Incheon, the company plans to launch cell cul...

2021-11-25 12:42 2869

USANA Assists Philippine Basketball Association As Nutritional Partner

USANA Named The Official Nutritional Supplements of the PBA SALT LAKE CITY, Nov. 25, 2021 /PRNewswire/ -- As USANA, the Cellular Nutrition Company, looks to its 30th anniversary next spring, it continues to showcase and build its elite and diverse athletic partnerships. For more than two decades...

2021-11-25 06:17 3798

Global Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2022

Added 19,066 New Subscribers in 2Q22 Revenues Up 9.8% YoY to RMB313.7 Million ($48.7 Million)         Gross Profit Up 11.0% YoY to RMB267.5 Million ($41.5 Million) Operating Income Up 15.3% YoY to RMB160.5 Million ($24.9 Million) Non-GAAP Operating Income Up 14.1% YoY to RMB172.8 Million ($26.8 Mi...

2021-11-25 05:16 4791

iX Biopharma Signs Exclusive License Agreement For Wafermine And Other Sublingual Ketamine Wafer Products

* iX Biopharma will receive an initial US$9 million upfront payment * Eligible for up to US$239 million in development and sales milestone payments * Double digit royalties on future product sales of any licensed product SINGAPORE, Nov. 25, 2021 /PRNewswire/ -- iX Biopharma Ltd (SGX:42C), a ...

2021-11-25 00:18 4900

Kintor Pharma Receives IND Clearance by NMPA for KX-826's Pivotal Study to Treat Male Alopecia Patients

SUZHOU, China, Nov. 24, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, today announced that the IND application for the pivotal study (phase III stage) of p...

2021-11-24 23:14 3257

Novavax Files for Interim Authorization of COVID-19 Vaccine in Singapore

GAITHERSBURG, Md., Nov. 24, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced its submission to the Singapore Health Sciences Authority (HSA) for interim ...

2021-11-24 22:15 3412

Neurophth Therapeutics Strengthens Leadership Team with Appointment of Su Zhang as Chief Financial Officer

SHANGHAI and SAN DIEGO, Nov. 24, 2021 /PRNewswire/ -- Neurophth Biotechnology Ltd., a fully-integrated genomic medicines company seeking to improve lives through the curative potential of gene therapies, today announced the recent appointment ofSu Zhang, M.B.A., as the Chief Financial Officer (CF...

2021-11-24 21:30 2626

GreenLight Biosciences and Samsung Biologics announce collaboration to build capacity for messenger RNA Vaccine Manufacturing

BOSTON and INCHEON, South Korea, Nov. 24, 2021 /PRNewswire/ -- GreenLight Biosciences (Nasdaq: ENVI), a biotechnology company dedicated to making ribonucleic acid (RNA) products affordable and accessible for human health and agriculture, and Environmental Impact Acquisition Corp, and Samsung Biol...

2021-11-24 20:00 3048

Delta Featured Its New Delta U+ Far-UVC Light Care 222(R) Series at Industrial Transformation ASIA-PACIFIC (ITAP) 2021

SINGAPORE, Nov. 24, 2021 /PRNewswire/ -- Delta Electronics Int'l (Singapore), a provider of power and thermal management solutions, featured a range of solutions at the fourth edition of the Industrial TransformationASIA-PACIFIC (ITAP) on 22 to24 November 2021. They include the new Delta U+ Far-U...

2021-11-24 17:36 2717

Next-generation Precision Medicine Company Allorion Therapeutics Completes Series A Financing Round

BOSTON, Nov. 24, 2021 /PRNewswire/ -- Allorion Therapeutics, a company focusing on next-generation precision medicine for oncology and autoimmune disease, today announced the completion of$40M Series A financing. This financing round is led by Qiming Venture Partners and participated by IDG Capit...

2021-11-24 16:11 2235

Amgen and Bushu Pharma Announce Expanded Supply Chain Partnership across Japan and Asia-Pacific Region

KAWAGOE, Japan, Nov. 24, 2021 /PRNewswire/ -- Bushu Pharmaceuticals Ltd. ("Bushu Pharma") has agreed on an expanded partnership with Amgen Inc. and Amgen K.K. to provide its "Gateway toAsia" service to four countries across the Asia-Pacific region as Amgen's contract manufacturing organization (C...

2021-11-24 15:00 3152

Mannin GmbH Implements CDD Vault Informatics Platform to Facilitate Data Management and Collaboration

LEIPZIG, Germany and SAN FRANCISCO, Nov. 24, 2021 /PRNewswire/ -- Mannin GmbH, a biotechnology company specializing in the research and development for new vascular therapeutics, announced today that it has implemented CDD Vault in its Leipzig laboratories. CDD Vault, a hosted chemistry and biolog...

2021-11-24 13:57 2651

World's First|Aopeng Medical Completes Clinical Trial of Robotic-Assisted Peripheral artery Intervention of iliac artery in human

SHANGHAI, Nov. 23, 2021 /PRNewswire/ -- On November , 2021, Aopeng Medical's ALLVAS™ Endovascular Intervention Surgical Robot, successfully completed the first-in-human clinical evaluation of robot-assisted peripheral artery intervention of iliac artery in the Department of Vascular Surgery at Sh...

2021-11-24 11:30 2435

IND Application for Phase 3 Registration Study of KN046 in Combination with Chemotherapy for the Treatment of Pancreatic Cancer was Approved by CDE

SUZHOU, China, Nov. 24, 2021 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the IND application for phase 3 registration study (KN046-303) of the PD-L1/CTLA-4 bispecific antibody KN046 plus nab-paclitaxel/gemcitabine for the treatment of advanced pancreatic ductal adenoca...

2021-11-24 09:35 3104

Everest Medicines Announces Inclusion in the MSCI Global Small Cap Indexes - MSCI China Index

SHANGHAI, Nov. 23, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest" or the "Company"), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients inAsia, today announced that th...

2021-11-24 08:00 2905

Everest Medicines Announces Inclusion in the MSCI Global Small Cap Indexes - MSCI China Index

SHANGHAI, Nov. 24, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest" or the "Company"), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients inAsia, today announced that th...

2021-11-24 08:00 3993
1 ... 618619620621622623624 ... 643

Week's Top Stories